NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) today announced that AstraZeneca PLC – ADR (Nasdaq:AZN), will become a component of the NASDAQ-100 Index® (Nasdaq:NDX) and the NASDAQ-100 Equal Weighted Index (Nasdaq:NDXE) prior to market open on Tuesday, February 22, 2022. AstraZeneca PLC – ADR will replace Xilinx, Inc. (Nasdaq:XLNX) in the NASDAQ-100 Index® and the NASDAQ-100 Equal Weighted Index.
AstraZeneca PLC – ADR to Join the NASDAQ-100 Index Beginning February 22, 2022
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here